Skip to main content
. 2011 Sep 21;6(9):e25192. doi: 10.1371/journal.pone.0025192

Figure 7. Effect of 15d-PGJ2 and its analog CAY-10410 on SIRT1 and HDAC1 activity.

Figure 7

(A) Chemical structures of 15d-PGJ2 (15-deoxy-Δ12,14-Prostaglandin J2) and its analog CAY-10410 (9,10-dihydro-15-deoxy-Δ12,14-Prostaglandin J2). Asterisk indicates the electrophilic carbon atoms which might be involved in Michael addition reaction. Panel (A) and (B) show the concentration-dependent effects of 15d-PGJ2, CAY-10410 and ciglitazone on the deacetylase activity of SIRT1 and HDAC1, respectively using in vitro enzyme assays. #P<0.01 versus ciglitazone, p<0.05 and ††p<0.01 versus CAY-10410. (D) Effect of CAY-10410 on the cell viability of A2780 and A2780/AD cells as measured with an alamar blue assay. (E) Treatment with CAY-10410 (2.5 µM) did not induce cell transformation after 48 h incubation. Magnification, 200×.